366 related articles for article (PubMed ID: 17440109)
1. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
Song P; Sekhon HS; Lu A; Arredondo J; Sauer D; Gravett C; Mark GP; Grando SA; Spindel ER
Cancer Res; 2007 Apr; 67(8):3936-44. PubMed ID: 17440109
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma.
Song P; Sekhon HS; Jia Y; Keller JA; Blusztajn JK; Mark GP; Spindel ER
Cancer Res; 2003 Jan; 63(1):214-21. PubMed ID: 12517800
[TBL] [Abstract][Full Text] [Related]
3. Expression of catalytically inactive phospholipase Cbeta disrupts phospholipase Cbeta and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth.
Beekman A; Helfrich B; Bunn PA; Heasley LE
Cancer Res; 1998 Mar; 58(5):910-3. PubMed ID: 9500449
[TBL] [Abstract][Full Text] [Related]
4. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
Zhao Q; Gu X; Zhang C; Lu Q; Chen H; Xu L
Cancer Biol Ther; 2015; 16(4):634-43. PubMed ID: 25778781
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of cholinergic receptors in small cell lung cancer cells.
Zhang S; Togo S; Minakata K; Gu T; Ohashi R; Tajima K; Murakami A; Iwakami S; Zhang J; Xie C; Takahashi K
Anticancer Res; 2010 Jan; 30(1):97-106. PubMed ID: 20150622
[TBL] [Abstract][Full Text] [Related]
6. Activated cholinergic signaling provides a target in squamous cell lung carcinoma.
Song P; Sekhon HS; Fu XW; Maier M; Jia Y; Duan J; Proskosil BJ; Gravett C; Lindstrom J; Mark GP; Saha S; Spindel ER
Cancer Res; 2008 Jun; 68(12):4693-700. PubMed ID: 18559515
[TBL] [Abstract][Full Text] [Related]
7. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway.
Péqueux C; Keegan BP; Hagelstein MT; Geenen V; Legros JJ; North WG
Endocr Relat Cancer; 2004 Dec; 11(4):871-85. PubMed ID: 15613460
[TBL] [Abstract][Full Text] [Related]
9. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
[TBL] [Abstract][Full Text] [Related]
10. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.
Spruce BA; Campbell LA; McTavish N; Cooper MA; Appleyard MV; O'Neill M; Howie J; Samson J; Watt S; Murray K; McLean D; Leslie NR; Safrany ST; Ferguson MJ; Peters JA; Prescott AR; Box G; Hayes A; Nutley B; Raynaud F; Downes CP; Lambert JJ; Thompson AM; Eccles S
Cancer Res; 2004 Jul; 64(14):4875-86. PubMed ID: 15256458
[TBL] [Abstract][Full Text] [Related]
11. Selective M3 muscarinic receptor antagonist inhibits small-cell lung carcinoma growth in a mouse orthotopic xenograft model.
Ami N; Koga K; Fushiki H; Ueno Y; Ogino Y; Ohta H
J Pharmacol Sci; 2011; 116(1):81-8. PubMed ID: 21512307
[TBL] [Abstract][Full Text] [Related]
12. In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice.
Yamada S; Maruyama S; Takagi Y; Uchida S; Oki T
Life Sci; 2006 Dec; 80(2):127-32. PubMed ID: 16996089
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
[TBL] [Abstract][Full Text] [Related]
14. Specificity of g protein-coupled receptor kinase 6-mediated phosphorylation and regulation of single-cell m3 muscarinic acetylcholine receptor signaling.
Willets JM; Mistry R; Nahorski SR; Challiss RA
Mol Pharmacol; 2003 Nov; 64(5):1059-68. PubMed ID: 14573754
[TBL] [Abstract][Full Text] [Related]
15. Effects of neuropeptide analogues on calcium flux and proliferation in lung cancer cell lines.
Bunn PA; Chan D; Stewart J; Gera L; Tolley R; Jewett P; Tagawa M; Alford C; Mochzuki T; Yanaihara N
Cancer Res; 1994 Jul; 54(13):3602-10. PubMed ID: 7516822
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt.
Yeh J; Litz J; Hauck P; Ludwig DL; Krystal GW
Lung Cancer; 2008 May; 60(2):166-74. PubMed ID: 18006183
[TBL] [Abstract][Full Text] [Related]
18. Broad spectrum neuropeptide antagonists inhibit the growth of small cell lung cancer in vivo.
Langdon S; Sethi T; Ritchie A; Muir M; Smyth J; Rozengurt E
Cancer Res; 1992 Aug; 52(16):4554-7. PubMed ID: 1379515
[TBL] [Abstract][Full Text] [Related]
19. Critical role of G(alpha)12 and G(alpha)13 for human small cell lung cancer cell proliferation in vitro and tumor growth in vivo.
Grzelinski M; Pinkenburg O; Büch T; Gold M; Stohr S; Kalwa H; Gudermann T; Aigner A
Clin Cancer Res; 2010 Mar; 16(5):1402-15. PubMed ID: 20160064
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of acetylcholine by lung cancer.
Song P; Sekhon HS; Proskocil B; Blusztajn JK; Mark GP; Spindel ER
Life Sci; 2003 Mar; 72(18-19):2159-68. PubMed ID: 12628474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
